+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The relationship between pleural fluid findings and the development of pleural thickening in patients with pleural tuberculosis



The relationship between pleural fluid findings and the development of pleural thickening in patients with pleural tuberculosis



Chest 100(5): 1264-1267



The objective of the study was to determine if residual pleural thickening after treatment for pleural tuberculosis could be predicted from the pleural fluid findings at the time of the initial thoracentesis. Forty-four patients initially diagnosed as having pleural tuberculosis between January 1986 and January 1988 were separated into two groups: the 23 patients in group 1 had residual pleural disease, while the 21 patients in group 2 had no residual pleural disease after treatment for their pleural tuberculosis was completed. The clinical characteristics of the two different groups did not differ significantly, but the patients in group 1 tended to be a little sicker in that the duration of their symptoms was longer, their hemoglobin values were lower, and weight loss and cough were more frequent. There were no significant differences in the pleural fluid findings in the two different groups. The mean pleural fluid protein level was 5.40 .+-. 0.58 g/dl for group 1 and 5.17 .+-. 0.80 g/dl for group 2, while the mean pleural fluid glucose level was 78.6 .+-. 19.5 mg/dl for group 1 and 79.5 .+-. 20.1 mg/dl for group 2. The mean pleural fluid lactate dehydrogenase (LDH) level in group 1 was 593 .+-. 498 IU/L, while the mean level for group 2 was 491 .+-. 198 IU/L. The presence of residual pleural thickening was not related to the chemotherapeutic regimen or the performance of a therapeutic thoracentesis. From this study we conclude that approximately 50 percent of patients with pleural tuberculosis will have residual pleural thickening when their therapy is completed, but that one cannot predict which patients will have residual pleural thickening from either their clinical characteristics or their pleural fluid findings.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 007928720

Download citation: RISBibTeXText

PMID: 1935279

DOI: 10.1378/chest.100.5.1264


Related references

Are pleural fluid parameters related to the development of residual pleural thickening in tuberculosis?. Chest 112(5): 1293-1297, 1997

VEGF (vascular endothelial growth factor) concentration in serum and pleural fluid of patients with pleural malignancy and pleural tuberculosis. Pneumonologia i Alergologia Polska 70(9-10): 458-467, 2003

Clinical value of jointly detection pleural fluid Midkine, pleural fluid adenosine deaminase, and pleural fluid carbohydrate antigen 125 in the identification of nonsmall cell lung cancer-associated malignant pleural effusion. Journal of Clinical Laboratory Analysis 32(8): E22576, 2018

Diagnostic Value of Quantitative Measurement of Pleural Fluid Interferon-Gamma (IFN - ) Versus QuantiFERON-TB Gold in Tube Assays (QFT-IT) in Blood, Pleural Fluid, and Isolated Pleural Fluid Cells in Tuberculous Pleural Effusion. Chest Journal 144(4): 262a-262b, 2013

Pleural thickening, trapped lung, and chronic empyema as sequelae of tuberculous pleural effusion: don't sweat the pleural thickening. International Journal of Tuberculosis and Lung Disease 6(6): 461-464, 2002

Rapid diagnosis of pleural tuberculosis by Xpert MTB/RIF assay using pleural biopsy and pleural fluid specimens. Journal of Research in Medical Sciences 20(1): 26-31, 2015

Chest CT findings of pleural tuberculosis: differential diagnosis of pleural tuberculosis and malignant pleural dissemination. Acta Radiologica 55(9): 1063-1068, 2014

Serial blood pleural fluid glucose and pleural fluid ph and carbon dioxide partial pressure relationship the mechanisms of low pleural fluid glucose in acidotic fluid and pleural fluid to blood glucose ratios. Journal of the Medical Association of Thailand 71(1): 47-53, 1988

Pleural thickening in patients with pleural tuberculosis. Chest 105(4): 1296, 1994

The neuro-endocrine-immune relationship in pulmonary and pleural tuberculosis: a better local profile in pleural fluid. International Journal of Tuberculosis and Lung Disease 22(3): 321-327, 2018

Asbestos-related pleural diseases: dimensional criteria are not appropriate to differentiate diffuse pleural thickening from pleural plaques. American Journal of Industrial Medicine 45(3): 289-296, 2004

Pleural fluid cytological yield and visceral pleural invasion in patients with epithelioid malignant pleural mesothelioma. Journal of Thoracic Oncology 7(3): 595-598, 2012

Pleural tuberculosis: a key differential diagnosis for pleural thickening, even without obvious risk factors for tuberculosis in a low incidence setting. BMJ Case Reports 2018, 2018

Tissue inhibitor of metalloproteinase-1 is responsible for residual pleural thickening in pleural tuberculosis. Tohoku Journal of Experimental Medicine 235(4): 327-333, 2015

Distinguishing tuberculosis pleural effusion from parasitic pleural effusion using pleural fluid characteristics: A case control study. Medicine 98(5): E14238-E14238, 2019